OBI Pharma Inc (4174):財務・戦略的SWOT分析

◆英語タイトル:OBI Pharma Inc (4174) - Financial and Strategic SWOT Analysis Review
◆レポート形式:英語 / PDF
◆産業分野:Pharmaceuticals and Healthcare
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム


OBI Pharma Inc (OBI Pharma) is a biopharmaceutical company that develops therapies for the treatment of cancer and infectious diseases. The company’s products include adagloxad simolenin, an active immunotherapy which is intended for the treatment of metastatic breast cancer; and OBI-833, a cancer vaccine for epithelial cancers other than breast and ovarian cancer. It also develops active immunotherapies intended for the treatment of various lung, prostate, pancreatic, stomach and ovarian cancers. OBI Pharma develops its pipeline products through its carbohydrate synthesis discovery platform. The company has collaboration with research institutes including cancer centers to enhance its pipeline products. It operates in the US, Taiwan and China. OBI Pharma is headquartered in Taipei, Taiwan.

OBI Pharma Inc Key Recent Developments

Jan 11,2021: OBI Pharma, Inc. to Present at the 39th J.P. Morgan Healthcare Conference
Sep 28,2020: Taiwan Hao Ding held a major news press conference

This comprehensive SWOT profile of OBI Pharma Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of OBI Pharma Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

OBI Pharma Inc – Key Information
OBI Pharma Inc – Overview
OBI Pharma Inc – Key Employees
OBI Pharma Inc – Key Employee Biographies
OBI Pharma Inc – Key Operational Heads
OBI Pharma Inc – Major Products and Services
OBI Pharma Inc – History
OBI Pharma Inc – Company Statement
OBI Pharma Inc – Locations And Subsidiaries
OBI Pharma Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

OBI Pharma Inc – Business Description
OBI Pharma Inc – Corporate Strategy
OBI Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
OBI Pharma Inc – Strengths
OBI Pharma Inc – Weaknesses
OBI Pharma Inc – Opportunities
OBI Pharma Inc – Threats
OBI Pharma Inc – Key Competitors

Section 3 – Company Financial Performance Charts

OBI Pharma Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

OBI Pharma Inc, Key Information
OBI Pharma Inc, Key Ratios
OBI Pharma Inc, Share Data
OBI Pharma Inc, Major Products and Services
OBI Pharma Inc, History
OBI Pharma Inc, Key Employees
OBI Pharma Inc, Key Employee Biographies
OBI Pharma Inc, Key Operational Heads
OBI Pharma Inc, Other Locations
OBI Pharma Inc, Subsidiaries
OBI Pharma Inc, Key Competitors
OBI Pharma Inc, SWOT Analysis
OBI Pharma Inc, Ratios based on current share price
OBI Pharma Inc, Annual Ratios
OBI Pharma Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios


★リサーチレポート[ OBI Pharma Inc (4174):財務・戦略的SWOT分析(OBI Pharma Inc (4174) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。